These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Diagnostic Limitation of Fine-Needle Aspiration (FNA) on Indeterminate Thyroid Nodules Can Be Partially Overcome by Preoperative Molecular Analysis: Assessment of RET/PTC1 Rearrangement in BRAF and RAS Wild-Type Routine Air-Dried FNA Specimens. Ko YS; Hwang TS; Kim JY; Choi YL; Lee SE; Han HS; Kim WS; Kim SK; Park KS Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417935 [TBL] [Abstract][Full Text] [Related]
23. DNA fragile site breakage as a measure of chemical exposure and predictor of individual susceptibility to form oncogenic rearrangements. Lehman CE; Dillon LW; Nikiforov YE; Wang YH Carcinogenesis; 2017 Mar; 38(3):293-301. PubMed ID: 28069693 [TBL] [Abstract][Full Text] [Related]
24. Formation of carcinogenic chromosomal rearrangements in human thyroid cells after induction of double-strand DNA breaks by restriction endonucleases. Evdokimova V; Gandhi M; Rayapureddi J; Stringer JR; Nikiforov YE Endocr Relat Cancer; 2012 Jun; 19(3):271-81. PubMed ID: 22323563 [TBL] [Abstract][Full Text] [Related]
25. BRAF(V600E) Mutation, RET/PTC1 and PAX8-PPAR Gamma Rearrangements in Follicular Epithelium Derived Thyroid Lesions - Institutional Experience and Literature Review. Şahpaz A; Önal B; Yeşilyurt A; Han Ü; Delibaşı T Balkan Med J; 2015 Apr; 32(2):156-66. PubMed ID: 26167339 [TBL] [Abstract][Full Text] [Related]
26. RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho. Barone MV; Sepe L; Melillo RM; Mineo A; Santelli G; Monaco C; Castellone MD; Tramontano D; Fusco A; Santoro M Oncogene; 2001 Oct; 20(48):6973-82. PubMed ID: 11704822 [TBL] [Abstract][Full Text] [Related]
27. Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese. Liu RT; Chou FF; Wang CH; Lin CL; Chao FP; Chung JC; Huang CC; Wang PW; Cheng JT Thyroid; 2005 Apr; 15(4):326-35. PubMed ID: 15876154 [TBL] [Abstract][Full Text] [Related]
28. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Nikiforov YE; Rowland JM; Bove KE; Monforte-Munoz H; Fagin JA Cancer Res; 1997 May; 57(9):1690-4. PubMed ID: 9135009 [TBL] [Abstract][Full Text] [Related]
29. Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma. Rhoden KJ; Johnson C; Brandao G; Howe JG; Smith BR; Tallini G Lab Invest; 2004 Dec; 84(12):1557-70. PubMed ID: 15502856 [TBL] [Abstract][Full Text] [Related]
30. Src inhibitors in suppression of papillary thyroid carcinoma growth. Henderson YC; Toro-Serra R; Chen Y; Ryu J; Frederick MJ; Zhou G; Gallick GE; Lai SY; Clayman GL Head Neck; 2014 Mar; 36(3):375-84. PubMed ID: 23729178 [TBL] [Abstract][Full Text] [Related]
31. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma. Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592 [TBL] [Abstract][Full Text] [Related]
32. Concurrent overexpression of RET/PTC1 and TTF1 confers tumorigenicity to thyrocytes. Endo T; Kobayashi T Endocr Relat Cancer; 2013 Dec; 20(6):767-76. PubMed ID: 24014739 [TBL] [Abstract][Full Text] [Related]
33. Thyroid carcinomas in RET/PTC transgenic mice. Jhiang SM; Cho JY; Furminger TL; Sagartz JE; Tong Q; Capen CC; Mazzaferri EL Recent Results Cancer Res; 1998; 154():265-70. PubMed ID: 10027006 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of homologous recombination by variants of the catalytic subunit of the DNA-dependent protein kinase (DNA-PKcs). Convery E; Shin EK; Ding Q; Wang W; Douglas P; Davis LS; Nickoloff JA; Lees-Miller SP; Meek K Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1345-50. PubMed ID: 15668400 [TBL] [Abstract][Full Text] [Related]
35. Microhomology-mediated end joining: Good, bad and ugly. Seol JH; Shim EY; Lee SE Mutat Res; 2018 May; 809():81-87. PubMed ID: 28754468 [TBL] [Abstract][Full Text] [Related]
36. [Rearrangement of the RET gene in papillary thyroid carcinoma]. Wiench M; Włoch J; Oczko M; Gubała E; Jarzab B Wiad Lek; 2001; 54 Suppl 1():64-71. PubMed ID: 12182064 [TBL] [Abstract][Full Text] [Related]
37. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Klugbauer S; Lengfelder E; Demidchik EP; Rabes HM Oncogene; 1995 Dec; 11(12):2459-67. PubMed ID: 8545102 [TBL] [Abstract][Full Text] [Related]
38. Creation and characterization of a doxycycline-inducible mouse model of thyroid-targeted RET/PTC1 oncogene and luciferase reporter gene coexpression. Knostman KA; Venkateswaran A; Zimmerman B; Capen CC; Jhiang SM Thyroid; 2007 Dec; 17(12):1181-8. PubMed ID: 18004977 [TBL] [Abstract][Full Text] [Related]
39. Loss of One or Two PATZ1 Alleles Has a Critical Role in the Progression of Thyroid Carcinomas Induced by the RET/PTC1 Oncogene. Monaco M; Palma G; Vitiello M; Capiluongo A; D'Andrea B; Vuttariello E; Luciano A; Cerchia L; Chiappetta G; Arra C; Fusco A; Fedele M Cancers (Basel); 2018 Mar; 10(4):. PubMed ID: 29584698 [TBL] [Abstract][Full Text] [Related]
40. Prevalence of RET/PTC1 and RET/PTC3 gene rearrangements in Chennai population and its correlation with clinical parameters. Rao PJ; Vardhini NV; Parvathi MV; Murthy PB; Sudhakar G Tumour Biol; 2014 Oct; 35(10):9539-48. PubMed ID: 24957039 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]